The pipecolinate derivative biricodar (VX-710) is a clinically applicable modulator of P-glycoprotein (Pgp) and multidrug resistance protein (MRP-1).
The pipecolinate derivative biricodar (VX-710) is a clinically applicable modulator of P-glycoprotein (Pgp) and multidrug resistance protein (MRP-1).
Administered intravenously, biricodar dicitrate is to be used in combination with cancer chemotherapy agents.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.